Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants

NCT04301310 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Healthy Participants

Interventions

DRUG: BMS-986235 (Treatment A)
DRUG: Rifampin (Treatment B)

Sponsor

Bristol-Myers Squibb